Rebecca Guntern has been appointed Chief Commercial Officer effective September 1, 2024. Previously she led the European commercial organization as President Europe across more than 40 countries, beginning in 2020. She is a senior business leader with over 25 years of international experience in the pharmaceutical and healthcare industry. She joined Sandoz in 2007 as Head of Sales and has held positions of increasing leadership responsibility since then. Prior to joining Sandoz, Rebecca Guntern worked for other leading pharmaceutical companies such as Roche and Merck Sharpe & Dohme. Rebecca Guntern is also a member of the board of directors of BKW AG in Switzerland, where she chairs the nomination and compensation committee. She holds a master’s degree in pharmacy from the University of Basel as well as a bachelor’s degree in business administration.